Perrigo Picks Former Bayer Executive As New CEO
Portfolio Pulse from Lekha Gupta
Perrigo Co has appointed Patrick Lockwood-Taylor as its new President, CEO, and Board member, effective June 30, 2023. Lockwood-Taylor previously served at Bayer AG as President of the U.S. business and Regional President of Consumer Health North America. Perrigo reported Q1 FY23 sales of $1.18 billion and adjusted EPS of $0.45.
June 08, 2023 | 1:39 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Former Bayer executive Patrick Lockwood-Taylor appointed as Perrigo's new CEO.
The news of a former Bayer executive being appointed as Perrigo's new CEO may have some impact on Bayer's reputation, but it is unlikely to have a significant short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 40
RELEVANCE 50
NEUTRAL IMPACT
Perrigo appoints Patrick Lockwood-Taylor as new CEO, effective June 30, 2023. Q1 FY23 sales of $1.18 billion and adjusted EPS of $0.45.
The appointment of a new CEO with experience in the industry may bring positive changes to the company, but the short-term impact on the stock price is uncertain. The Q1 FY23 sales and adjusted EPS beat consensus, but the stock is trading lower by 0.58%.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100